Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11485960 RNA polymerase variants for co-transcriptional capping

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 1, 2022

Patent Application Number

17325883

Date Filed

May 20, 2021

Patent Citations

US Patent 10144942 Modification of RNA-related enzymes for enhanced production

US Patent 10034951 Use of thermostable RNA polymerases to produce RNAs having reduced immunogenicity

US Patent 10064934 Combination PIV3/hMPV RNA vaccines

US Patent 10064935 Human cytomegalovirus RNA vaccines

US Patent 10124055 Zika virus RNA vaccines

US Patent 10207010 Compositions and methods for delivery of agents

US Patent 10232055 RNA containing modified nucleosides and methods of use thereof

US Patent 10273269 High potency immunogenic zika virus compositions

...

Patent Citations Received

US Patent 12070495 HIV RNA vaccines

0

US Patent 11767548 RNA polymerase variants

US Patent 11786607 RNA formulations

US Patent 11866696 Analytical HPLC methods

0

US Patent 11872278 Combination HMPV/RSV RNA vaccines

0

US Patent 11905525 Reduction of elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins

0

US Patent 11911453 RSV RNA vaccines

0

US Patent 11912982 Methods for HPLC analysis

0

...

Patent Primary Examiner

CPC Code

C12N 2710/20034

The present disclosure provides RNA polymerase variants for high efficiency transcription.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11485960 RNA polymerase variants for co-transcriptional capping

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool